Cargando…
Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
We show that treatment with the FDA-approved anti-parasitic drug ivermectin induces immunogenic cancer cell death (ICD) and robust T cell infiltration into breast tumors. As an allosteric modulator of the ATP/P2X4/P2X7 axis which operates in both cancer and immune cells, ivermectin also selectively...
Autores principales: | Draganov, Dobrin, Han, Zhen, Rana, Aamir, Bennett, Nitasha, Irvine, Darrell J., Lee, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925581/ https://www.ncbi.nlm.nih.gov/pubmed/33654071 http://dx.doi.org/10.1038/s41523-021-00229-5 |
Ejemplares similares
-
Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy
por: Dörrie, Jan
Publicado: (2016) -
Targeting phosphatidylserine synergizes with immune checkpoint blockade by inducing de novo tumor specific immunity
por: Huang, Xianming, et al.
Publicado: (2015) -
On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition
por: Liu, Xiaoqing, et al.
Publicado: (2023) -
Converting Immune Cold into Hot by Biosynthetic Functional Vesicles to Boost Systematic Antitumor Immunity
por: Wu, Ming, et al.
Publicado: (2020) -
PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
por: Viramontes, Karla M., et al.
Publicado: (2022)